Navigation Links
Pharmacyclics Reports Financial Results and Recent Developments for Fiscal Year and Fourth Quarter 2011 - Conference Call Set for Today at 4:30 PM EDT
Date:9/12/2011

SUNNYVALE, Calif., Sept. 12, 2011 /PRNewswire/ -- Pharmacyclics, Inc. (Nasdaq: PCYC) today reported financial results and recent developments for its fiscal year and fourth quarter ended June 30, 2011.

Financial Results for Year and Fourth Quarter Ended June 30, 2011 The non-GAAP (Generally Accepted Accounting Principles) net loss reported for the fiscal year ended June 30, 2011 was $28.0 million, or $0.47 per share. This compares with a non-GAAP net loss of $13.6 million, or $0.28 per share, for the year ended June 30, 2010. For the quarter ended June 30, 2011 the non-GAAP net loss was $9.1 million, or $0.15 per share, which compares with a non-GAAP net loss of $4.9 million, or $0.10 per share for the 2010 quarter.  See "Use of Non-GAAP Financial Measures" below for a description of our non-GAAP measures.  Reconciliation between certain GAAP and non-GAAP measures is provided at the end of this press release.

The GAAP net loss for the fiscal year ended June 30, 2011 was $35.2 million, or $0.59 per share. This compares with a GAAP net loss of $15.0 million, or $0.31 per share for the year ended June 30, 2010.  For the quarter ended June 30, 2011, the GAAP net loss was $11.0 million or $0.18 per share, which compares with a GAAP net loss of $6.8 million, or $0.13 per share for the 2010 quarter.

At June 30, 2011, the company had cash, cash equivalents and marketable securities of $112.3 million, which compares with  $74.1 million at June 30, 2010.  During the quarter ended June 30, 2011 we raised a net of $56.0 million from the sale of approximately 6.4 million common shares and also received a $7.0 million advance development milestone payment from Les Laboratoires Servier under our collaboration agreement.

"Fiscal 2011 was a year to remember for Pharmacyclics. Our efforts to create a coming era of patient friendly, medicinal sol
'/>"/>

SOURCE Pharmacyclics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Pharmacyclics Announces Date of Fiscal Year End 2011 Financial Results and Conference Call
2. Pharmacyclics Reports Recent Developments From Clinical Studies of its Btk Inhibitor PCI-32765
3. Pharmacyclics Announces Oral Presentations and Clinical Update at Upcoming Medical Meetings
4. Pharmacyclics to Announce Third Quarter Fiscal 2011 Results and Host a Conference Call on May 4, 2011
5. Pharmacyclics to Announce Second Quarter Fiscal 2011 Results and Host a Conference Call on February 4, 2011
6. Pharmacyclics Reports Updated Clinical Results from its Phase IA Trial of its First in Human Btk-Inhibitor PCI-32765
7. Pharmacyclics Reports CLL Results from Preclinical and Clinical Studies of its Btk Inhibitor PCI-32765
8. Pharmacyclics Reports Financial Results for Fiscal 2010 and for Fourth Quarter 2010
9. Pharmacyclics Announces Date of Fiscal Year End 2010 Financial Results and Conference Call and Presentation at Stifel Nicolaus Healthcare Conference
10. Pharmacyclics to Present at Bank of America Merrill Lynch Healthcare Conference and MDB Bright Lights Conference
11. Pharmacyclics to Present at the RBC Capital Markets Healthcare Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... April 17, 2015 Contego Medical, the ... Protection™ filter platform for angioplasty balloon and stent ... million Series B financing round led by Hatteras ... a focus on medical devices, biopharmaceuticals, diagnostics and ... included Mountain Group Partners, Lookout Capital and Medical ...
(Date:4/17/2015)... LifeScienceIndustryResearch.com announces having a ... Global and China Lysine Industry to its research ... the deep research report in this field. For ... including definition, classification specifications, application, industry chain structure, ... Europe , Japan , ...
(Date:4/17/2015)... 2015 CVS Health Corporation (NYSE: CVS ... May 1, 2015, at 8:30 a.m. (EDT) with analysts ... An audio webcast of the conference call ... of the CVS Health website for all interested parties. ... webcast will be archived and available on the web ...
Breaking Medicine Technology:Contego Medical Closes $5.6 Million in Series B Funding 2Contego Medical Closes $5.6 Million in Series B Funding 3Lysine Market International (US, Europe, Japan) Research Analysis 2Lysine Market International (US, Europe, Japan) Research Analysis 3Lysine Market International (US, Europe, Japan) Research Analysis 4Lysine Market International (US, Europe, Japan) Research Analysis 5
... BETHESDA, Md., June 9, 2011 Vertex Pharmaceuticals Incorporated ... from an ongoing Phase 2 study evaluating combinations of ... defective protein that causes cystic fibrosis. The ... most common CF mutation, known as Delta F508. The ...
... June 9, 2011 Located in Doniphan, MO the Bureau of ... USA who cannot afford to pay for their prescriptions out-of-pocket. ... with the fear that they or a family member will not ... insurance or a drug benefit . Members of "Big Pharma" ...
Cached Medicine Technology:Phase 2 Study of Two Potential CF Therapies — VX-770 and VX-809 — Shows Promising Results in Patients with Most Common Mutation 2Bureau of Prescription Health Gives the Whole Truth (and Nothing But) About Free Medicine at FreeMedicine.com 2
(Date:4/18/2015)... French physician and gastronome Anthelme Brillat-Savarin ... he uttered, “Tell me what you eat, and I ... cope with stress or sadness has often been attributed ... otherwise. Data collected from their Emotional Eating Test ... eating, but for different reasons. , Collecting data from ...
(Date:4/17/2015)... 2015 Riviera Magazine has ... of the Gallery of Cosmetic Surgery in Newport ... experts. The publication focused on his expertise in ... fat grafting, eyelid surgery, laser resurfacing and rhinoplasty. , ... has resulted in thousands of satisfied patients across ...
(Date:4/17/2015)... April 17, 2015 In Defense of ... following statement: “On Wednesday April 15th, the European Parliament ... a resolution recognizing the Armenian Genocide, “paying tribute, on ... the one-and-a-half million innocent Armenian victims who perished in ... extols the EU for this timely and needed recognition ...
(Date:4/17/2015)... At the end of February 2015, ... “Salute to the Oscars” in the Stardust Penthouse on ... the impressive Los Angeles skyline. These events honoring the ... LA’s leading producer of sustainable product placement in TV ... premier providers of eco-friendly and socially conscious products and ...
(Date:4/17/2015)... 2015 Scientists from the Icahn ... of U.S. and Venezuelan researchers, have discovered the ... among an isolated tribe of Yanomami Amerindians in ... in the Yanomami, previously unexposed to antibiotics or ... that of people living in industrialized countries, and ...
Breaking Medicine News(10 mins):Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 2Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 3Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 4Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 5Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 6Health News:Orange County Facial Plastic Surgeon Featured in Premier Magazine Focused on Beauty 2Health News:Orange County Facial Plastic Surgeon Featured in Premier Magazine Focused on Beauty 3Health News:In Defense of Christians Condemns Armenian Genocide 2Health News:In Defense of Christians Condemns Armenian Genocide 3Health News:Choices Recovery Speaks with Dakota Hood of “The Hunger Games” about Addiction in Hollywood 2Health News:Mount Sinai Scientists Find Unprecedented Microbial Diversity in Isolated Amazonian Tribe Previously Unexposed to Antibiotics or Processed Foods 2Health News:Mount Sinai Scientists Find Unprecedented Microbial Diversity in Isolated Amazonian Tribe Previously Unexposed to Antibiotics or Processed Foods 3
... known is a silent killer because it often goes unnoticed. ... lead to a lot of complications such as heart attack, ... can be diagnosed by a very simple out patient examination ... inexpensive, but widely overlooked drugs may help many patients who ...
... Breast Cancer Awareness Month, a campaign that has boosted better treatments, ... is possible that even they may be a victim // of ... be worse than for women, mainly because of the lack of ... the symptoms: a lump, pain or sensitivity, or a clear or ...
... combat minor infections has always been a contentious point ... are generally used, amoxicillin was considered // the relatively ... University of Iowa have their way. , ,These ... infections caused sever damage to the developing permanent teeth. ...
... estimated to have the highest number of diabetics ... US following closely. Type II Diabetes, one of ... gaining // epidemic proportions throughout the world, with ... diseases. Since diabetes causes significant morbidity and mortality ...
... when it comes to surgery that has to be addressed ... extended by this unique patient. Therefore every attempt has to ... thought clowns only displayed their talent in the circus shows- ... operating room may relax anxious children who are about to ...
... of the most common causes of sexually transmitted infection (STI) ... exist, most of which are harmless. HPV is a virus, ... grow in the anal, genital, oral cavities or respiratory locations ... most easily recognized sign of genital HPV infection. The presence ...
Cached Medicine News:Health News:Common, cheaper drugs could be used to treat hypertension 2Health News:Men Victims Of Breast Cancer? 2Health News:A new anti diabetic drug on the anvil 2
Bottega Venetas new collection expresses a unique style and determined personality: discreet elegance and refined luxury are the themes that inspire the creation of these new models, destined to beco...
Classic, stylish, and preppy, this collection features men's, women's and unisex styles....
... the elegant and sophisticated woman, ... includes ophthalmic and sunwear styles. ... variety of shapes and colors, ... shapes and complexions. Many styles ...
The Nine West Eyewear collection is positioned to present today's styles with a sharp, edgy contemporary attitude tied into a clean design element....
Medicine Products: